The Group owns more than 300 kinds of medical devices and medicines with more than 30,000 specifications, mainly including infusion consumables, operating room series, medical catheters, cardiac stents and intracardiac consumables, indwelling needles and all kinds of shaped needles, blood purification equipments and consumables, orthopedic materials, medical equipments, therapeutic injections and other medicines, bio-diagnostic reagents, synthetic plasma, bio-implants, PVC and non-PVC raw materials, etc. It has become the world's most complete, safe and reliable, the most trusted and China's largest manufacturer of medical system solutions. The company has become the most complete, safe, reliable, trustworthy, and largest medical system solution manufacturer in the world. It is a national 863 industrialization base and a key high-tech enterprise of the National Torch Plan, and has been awarded as a leading enterprise of the industry, a leading enterprise of the sanitary material and pharmaceutical manufacturing industry, a national enterprise of abiding by the contract and keeping promise, a top 500 competitive enterprise of the Chinese large enterprise group, and a top 100 (sixth place) pharmaceutical industry enterprise of the whole country. Pharmaceutical Industry Top 100 (sixth), China Enterprise Informatization Top 500, National Top 500 Private Enterprises, China Patent Shandong Star Enterprise, China's most bidding strength of medical equipment brand suppliers first, Shandong Province, Shandong Province, Outstanding Contribution to Industry-University-Research Cooperation and Innovation Award, Shandong Province Top 100 Enterprises, Shandong Province, Best Corporate Citizen, Shandong Province, Shandong Province, the first batch of good faith demonstration enterprises and other honorary titles.
The company vigorously implement the brand strategy, strengthen scientific management, adhere to the quality policy of "meet and strive to exceed the customer's maximum demand", and establish and improve the quality management system Since 1998, the main products have passed ISO9000, EU CE certification, ISO13485 quality system certification, Since 1998, our main products have passed ISO9000, EU CE certification, ISO13485 quality system certification, China CMD certification, China 3C certification, GMP certification, and some of our products have passed the U.S. FDA510 license, and we are the first enterprise in the industry to pass ISO9000 certification. The testing center is accredited by the National Laboratory Accreditation Committee. "Jieri" is a well-known trademark in China, the first brand in China's medical equipment industry, a famous brand in China, and the first one of the most bidding strength enterprises in China's medical equipment industry. Our products are exported to more than 70 countries and regions.
The company has a sound technological innovation system, with a national technology center, national engineering laboratories, postdoctoral workstations, academician workstations in Shandong Province, provincial enterprise technology centers, Taishan Scholars Laboratory. Adhering to the road of cooperation between industry, academia and research, the company has established 9 R&D centers off-site with the Chinese Academy of Sciences (CAS) and its Dean Chun Institute of Applied Chemistry (CAIC), Dalian Institute of Chemical Physics (DICP), Shenyang Institute of Metals (SIOM), 301 Hospital, the Third Military Medical University (TMMU), Harvard University of Technology (HIT), Shenyang Pharmaceutical University (SPU), etc. The company has made great efforts to develop high technology and high value added products with independent intellectual property rights. -In 2010, it implemented the CAS*** High Technology Research and Development Program with the Chinese Academy of Sciences (CAS) to further enhance its capability of independent innovation. At present, Weigao owns more than 200 patented products, including 60 invention patents, more than 80 products fill the gaps in China and reach the advanced level at home and abroad, and some of them break the monopoly of multinational corporations, and more than 20 projects (cardiac stent, polysulfone membrane dialyzer, spinal endoprosthesis, central venous catheter, gene-protein A immunosorbent column, self-destructive safety syringes, plasma separator, and light-avoiding syringes, etc.) are It is included in various national plans and projects such as National Key Torch Plan, National 863 Plan, National High-Tech Industry Demonstration Project, National Key Industry Revitalization Plan and so on.
The company implements the strategy of going out and strengthens the international cooperation, and establishes the strategic cooperation relationship with Medtronic Inc. of the United States, Parsons Brinckerhoff International Inc. of Singapore, NIKKISO Corporation of Japan, Zenith Vision Inc. of the United States, IT Company of Korea, etc., and builds the R&D centers in the United States, Japan, the United Kingdom, Germany, and France, to absorb the global advanced technology of medical treatment.
Weigao Group actively participates in social welfare and charitable endeavors to repay the society. In recent years, it has carried out activities such as Weigao Bright Action, Weigao Love Project, Top Ten Filial Piety Stars Selection, subscription to charitable funds, natural disaster donations, etc., with a total donation of more than 200 million yuan.
Weigao takes the mission of "creating a healthy future together with the white-clothed messenger", establishes the core values of conscience, sincerity and loyalty, builds a century-long evergreen foundation, and strides forward to the vision goal of "being a world-competitive, Asia's leading, and the most respected medical device and pharmaceutical enterprise! We will make greater contributions to the healthy development of China's medical and healthcare industry by marching forward to the vision and goal of "world competitiveness, Asia's leading and most respected medical device and pharmaceutical enterprise".